Cyclerion Therapeutics Inc (CYCN) — Long-term Investment Intensity

Latest as of December 2025: 53.6%

Cyclerion Therapeutics Inc (CYCN) has a Long-term Investment Intensity of 53.6% as of December 2025. Long-term investments of $5.35 Million represent 53.6% of total assets of $9.98 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See what is Cyclerion Therapeutics Inc's book value for net asset value and shareholders' equity analysis.

LT Investment Intensity

53.6%
LT Investments / Total Assets

Long-term Investments

$5.35 Million
USD

Total Assets

$9.98 Million
USD

Country

USA
NASDAQ

Cyclerion Therapeutics Inc Long-term Investment Intensity (2023–2025)

This chart shows how Cyclerion Therapeutics Inc's Long-term Investment Intensity has evolved across 3 annual periods from 2023 to 2025. As of December 2025, the intensity stands at 53.6%, reflecting long-term investments of $5.35 Million against total assets of $9.98 Million USD. Also explore Cyclerion Therapeutics Inc total assets for the complete picture of this company's asset base.

Annual Long-term Investment Intensity for Cyclerion Therapeutics Inc (2023–2025)

The table below presents the year-by-year Long-term Investment Intensity for Cyclerion Therapeutics Inc from 2023 to 2025, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Cyclerion Therapeutics Inc stock valuation.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2025 53.6% $5.35 Million $9.98 Million ▼ -2.3 pp
2024 55.9% $5.35 Million $9.57 Million ▲ +15.9 pp
2023 40.0% $5.35 Million $13.37 Million
pp = percentage points